Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Extracorporeal treatment with high-volume continuous venovenous hemodiafiltration and charcoal-based sorbent hemoperfusion for severe metformin-associated lactic acidosis.

Garg SK, Singh O, Deepak D, Singh A, Yadav R, Vashist K.

Indian J Crit Care Med. 2016 May;20(5):295-8. doi: 10.4103/0972-5229.182205.

2.

Lactate clearance and metabolic aspects of continuous high-volume hemofiltration.

Cheungpasitporn W, Zand L, Dillon JJ, Qian Q, Leung N.

Clin Kidney J. 2015 Aug;8(4):374-7. doi: 10.1093/ckj/sfv045. Epub 2015 Jun 17.

3.
4.

Metformin-associated lactic acidosis (MALA): case files of the Einstein Medical Center medical toxicology fellowship.

Kopec KT, Kowalski MJ.

J Med Toxicol. 2013 Mar;9(1):61-6. doi: 10.1007/s13181-012-0278-3. Review. No abstract available.

5.

Management of metformin-associated lactic acidosis by continuous renal replacement therapy.

Keller G, Cour M, Hernu R, Illinger J, Robert D, Argaud L.

PLoS One. 2011;6(8):e23200. doi: 10.1371/journal.pone.0023200. Epub 2011 Aug 11.

6.

Clinical review: timing of renal replacement therapy.

Joannidis M, Forni LG.

Crit Care. 2011;15(3):223. doi: 10.1186/cc10109. Epub 2011 Jun 10. Review.

7.

Should dialysis be offered in all cases of metformin-associated lactic acidosis?

Finkle SN.

Crit Care. 2009;13(1):110. doi: 10.1186/cc7161. Epub 2009 Jan 9. Review.

8.

Metformin-associated lactic acidosis in an intensive care unit.

Peters N, Jay N, Barraud D, Cravoisy A, Nace L, Bollaert PE, Gibot S.

Crit Care. 2008;12(6):R149. doi: 10.1186/cc7137. Epub 2008 Nov 26.

Supplemental Content

Support Center